Flashpoint Therapeutics Unveils Novel HPV Vaccine Study
17 Feb 2026 //
BUSINESSWIRE
Flashpoint Therapeutics Appoints Venkat R., Ph.D. as CSO
14 Jan 2026 //
BUSINESSWIRE
Flashpoint Therapeutics` Founder Chad A. Mirkin Wins Harvey Prize
08 Dec 2025 //
BUSINESSWIRE
Flashpoint Shows Strong Preclinical Anti-Leukemia Results
13 Nov 2025 //
BUSINESSWIRE
Flashpoint Nanomedicine Platform Supports CRISPR Therapeutics
03 Sep 2025 //
PHARMAWEB
Flashpoint Therapeutics Names Barry Labinger as CEO
29 Jul 2025 //
CONTRACTPHARMA
Flashpoint Therapeutics Names Barry Labinger as CEO
28 Jul 2025 //
BUSINESSWIRE
Flashpoint Therapeutics Announces $50M KAIMRC Partnership
14 Nov 2024 //
PR NEWSWIRE
CancerVax Taps Flashpoint’s Nanotechnology for Universal Cancer Treatment
29 Aug 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support